Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7408-7417

  Pedron, Sara ^a   Becka, Eftalda ^a   Harley, Brendan A C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Biomimetic material; Brain; Cell activation; Gelatin; Hyaluronic acid hyaluronan; Hydrogel

Indexed keywords

CELL ACTIVATION; EPIDERMAL GROWTH FACTOR RECEPTORS; EXTRACELLULAR MATRIX COMPONENTS; EXTRACELLULAR MICROENVIRONMENT; GELATIN; GLIOBLASTOMA MULTIFORME; MALIGNANT TRANSFORMATIONS; THREE-DIMENSIONAL CULTURE;

BIOMIMETIC MATERIALS; BRAIN; CELLS; CYTOLOGY; ENZYME ACTIVITY; GENE EXPRESSION; GRAFTING (CHEMICAL); HYDROGELS; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; THREE DIMENSIONAL; TUMORS;

HYALURONIC ACID;

CD44V ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBRONECTIN; GELATIN; GELATINASE A; GELATINASE B; HYALURONIC ACID; MACROGOL;

ADHESION; ARTICLE; BEHAVIOR; BIOMECHANICS; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA CELL; HYDROGEL; PARTICLE SIZE; PHENOTYPE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION;

BIOMIMETIC MATERIAL; BRAIN; CELL ACTIVATION; GELATIN; HYALURONIC ACID/HYALURONAN; HYDROGEL;

ANIMALS; BRAIN NEOPLASMS; CELL AGGREGATION; CELL LINE, TUMOR; DIFFUSION; DNA; EXTRACELLULAR MATRIX; GELATIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; HYALURONIC ACID; HYDROGELS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUS SCROFA; UP-REGULATION;

EID: 84880509585     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.024     Document Type: Article

References (43)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
2. Bissell M.J., Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1:46-54.
3. Gladson C.L. The extracellular matrix of gliomas: modulation of cell function. JNeuropathol Exp Neurol 1999, 58:1029-1040.
4. Nakada M., Nakada S., Demuth T., Tran N.L., Hoelzinger D.B., Berens M.E. Molecular targets of glioma invasion. Cell Mol Life Sci 2007, 64:458-478.
5. Wiranowska M.R., Roijani M.V. Extracellular matrix microenvironment in glioma progression. Glioma - exploring its biology and practical relevance 2011, 257-284. InTech. A. Ghosh (Ed.).
6. Nakada M., Okada Y., Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci 2003, 8:E261-E269.
7. Bartek J., Ng K., Fischer W., Carter B., Chen C.C. Key concepts in glioblastoma therapy. JNeurol Neurosurg Psychiatry 2012, 83:753-760.
8. Sottoriva A., Spiteri I., Piccirillo S.G.M., Touloumis A., Collins V.P., Marioni J.C., et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 2013, 110:4009-4014.
9. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47.
10. Laurent T.C., Fraser J.R.E. Hyaluronan. FASEB J 1992, 6:2397-2404.
11. David L., Dulong V., Le Cerf D., Chauzy C., Norris V., Delpech B., et al. Reticulated hyaluronan hydrogels: a model for examining cancer cell invasion in 3D. Matrix Biol 2004, 23:183-193.
12. Delpech B., Maingonnat C., Girard N., Chauzy C., Maunoury R., Olivier A., et al. Hyaluronan and hyaluronectin in the extracellular matrix of human brain-tumor stroma. Eur J Cancer 1993, 29A:1012-1017.
13. Giese A., Loo M.A., Rief M.D., Tran N., Berens M.E. Substrates for astrocytoma invasion. Neurosurgery 1995, 37:294-301.
14. Turley E.A., Noble P.W., Bourguignon L.Y.W. Signaling properties of hyaluronan receptors. JBiol Chem 2002, 277:4589-4592.
15. Koochekpour S., Pilkington G.J., Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells invitro. Int J Cancer 1995, 63:450-454.
16. Tsatas D., Kanagasundaram V., Kaye A., Novak U. EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. JClin Neurosci 2002, 9:282-288.
17. Ananthanarayanan B., Kim Y., Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 2011, 32:7913-7923.
18. Jin S.-G., Jeong Y.-I., Jung S., Ryu H.-H., Jin Y.-H., Kim I.-Y. The effect of hyaluronic acid on the invasiveness of malignant glioma cells: comparison of invasion potential at hyaluronic acid hydrogel and matrigel. JKorean Neurosurg Soc 2009, 46:472-478.
19. Pedron S., Harley B.A.C. The impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy. JBiomed Mater Res Pt A 2013.
20. van den Bulcke A.I., Bogdanov B., De Rooze N., Schacht E.H., Cornelissen M., Berghmans H. Structural and rheological properties of methacrylamide modified gelatin hydrogels. Biomacromolecules 2000, 1:31-38.
21. Benton J.A., DeForest C.A., Vivekanandan V., Anseth K.S. Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function. Tissue Eng Part A 2009, 15:3221-3230.
22. Brinkman W.T., Nagapudi K., Thomas B.S., Chaikof E.L. Photo-cross-linking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function. Biomacromolecules 2003, 4:890-895.
23. Askeland D.R., Phule P.P. The science and engineering of materials 2003, Thomson, Brooks/Cole, Pacific Grove, CA. 4th ed.
24. Braeckmans K., Peeters L., Sanders N.N., De Smedt S.C., Demeester J. Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. Biophys J 2003, 85:2240-2252.
25. Nagane M., Lin H., Cavenee W.K., Huang H.J.S. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett 2001, 162:S17-S21.
26. Choi J.-S., Harley B.A. The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells. Biomaterials 2012, 33:4460-4468.
27. Duffy G.P., McFadden T.M., Byrne E.M., Gill S.L., Farrell E., O'Brien F.J. Towards invitro vascularisation of collagen-GAG scaffolds. Eur Cell Mater 2011, 21:15-30.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
29. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003, 3:489-501.
30. Ohnishi T., Hiraga S., Izumoto S., Matsumura H., Kanemura Y., Arita N., et al. Role of fibronectin-stimulated tumor cell migration in glioma invasion invivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues. Clin Exp Metastasis 1998, 16:729-741.
31. Krock B.L., Skuli N., Simon M.C. Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2011, 2:1117-1133.
32. Kaur B., Khwaja F.W., Severson E.A., Matheny S.L., Brat D.J., Van Meir E.G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005, 7:134-153.
33. Hardee M.E., Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol 2012, 181:1126-1141.
34. Mizukami Y., Jo W.S., Duerr E.M., Gala M., Li J.N., Zhang X.B., et al. Induction of interleukin-8 preserves the angiogenic response in HIF-1 alpha-deficient colon cancer cells. Nat Med 2005, 11:992-997.
35. Fischbach C., Kong H.J., Hsiong S.X., Evangelista M.B., Yuen W., Mooney D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci U S A 2009, 106:399-404.
36. Khain E., Sander L.M. Dynamics and pattern formation in invasive tumor growth. Phys Rev Lett 2006, 96.
37. Gabelloni P., Da Pozzo E., Bendinelli S., Costa B., Nuti E., Casalini F., et al. Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma. Neuroscience 2010, 168:514-522.
38. Raithatha S.A., Muzik H., Rewcastle N.B., Johnston R.N., Edwards D.R., Forsyth P.A. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol 2000, 2:145-150.
39. Lu K.V., Jong K.A., Rajasekaran A.K., Cloughesy T.F., Mischel P.S. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Invest 2004, 84:8-20.
40. Micke P., Ohshima M., Tahmasebpoor S., Ren Z.P., Ostman A., Ponten F., et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 2006, 86:202-211.
41. Ito T.K., Ishii G., Chiba H., Ochiai A. The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene 2007, 26:7194-7203.
42. Pandey V., Qian P.X., Kang J., Perry J.K., Mitchell M.D., Yin Z.N., et al. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells. Endocrinology 2010, 151:909-920.
43. Zhou J.A., Xu C.X., Wu G., Cao X.D., Zhang L.M., Zhai Z.C., et al. Invitro generation of osteochondral differentiation of human marrow mesenchymal stem cells in novel collagen-hydroxyapatite layered scaffolds. Acta Biomaterialia 2011, 7:3999-4006.